How to bring innovation into German routine clinical practice?
Hello! In this week’s post, I am describing the G-BA’s initiative to promote innovation in the German health care system and clinical
Category: News and updates
IQWiG methods for RWE collection for products of same active ingredient class
Recently, I have written about RWE collection, that can be mandated by the G-BA as part of their benefit assessment. Now, the
G-BA defines 4 strict requirements on cefiderocol use to protect its “reserve antibiotics” status
Currently, reserve antibiotics are excluded from a benefit assessment by the G-BA. The G-BA decides whether to accept a new antibiotic onto the
Virtual consultations for patients with Covid-19 requiring intensive care introduced into routine clinical practice
During the pandemic, the G-BA introduced special regulations for hospital care. Based on their good experiences with these, the G-BA has now
KBV and GKV-SV agreed new clinician fees for DiGAs in Germany
From medical devices last week, we are moving back to digital health applications (DiGAs), and how clinician fees are set for these